| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/16/2009 | WO2009012185A9 Polynucleotide capture materials, and methods of using same |
| 04/16/2009 | WO2009012110A3 Unique calibrator polynucleotides and methods of using in quantitative nucleic acid assays |
| 04/16/2009 | WO2009010240A9 Analysis of doping compounds |
| 04/16/2009 | WO2009009408A3 Devices and methods for the detection of analytes |
| 04/16/2009 | WO2009005688A3 Activating mutations in notch-1 |
| 04/16/2009 | WO2009001051A3 Fluorescence lifetime and fluorescence assays |
| 04/16/2009 | WO2008149124A3 Apparatus for determining the concentration of a conductive fluid present in a fluid filled borehole |
| 04/16/2009 | WO2008147988A9 Determination of the safety of foodstuffs for consumption |
| 04/16/2009 | WO2008147345A3 System and method for antigen structure-independent detection of antigens captured on antibody arrays |
| 04/16/2009 | WO2008137881A9 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| 04/16/2009 | WO2008137549A3 Methods and compositions for diagnosing osteoarthritis in a feline |
| 04/16/2009 | WO2008133936A3 Assays for the identification of compounds that modulate bone formation and mineralization |
| 04/16/2009 | WO2008133666A3 Quantitative, multispectral image analysis of tissue specimens stained with quantum dots |
| 04/16/2009 | WO2008130429A3 Detecting nitric oxide |
| 04/16/2009 | WO2008117067A8 Protein signature/markers for the detection of adenocarcinoma |
| 04/16/2009 | WO2008091696A4 Sorting of microdevices |
| 04/16/2009 | WO2008060713A3 Flow cytometry methods and immunodiagnostics with mass sensitive readout |
| 04/16/2009 | WO2008057111A3 Assay apparatuses, methods and reagents |
| 04/16/2009 | WO2008054600A3 Compositions and methods for biodetection by nucleic acid-templated chemistry |
| 04/16/2009 | WO2008048680A3 Notch 2 signaling as a breast cancer suppressor pathway |
| 04/16/2009 | WO2008045120A3 Transgenic mouse lines expressing human ace2 and uses thereof |
| 04/16/2009 | WO2008033164A8 Magnetic particle tagged reagents and techniques |
| 04/16/2009 | WO2008027548A3 Microarray-based global chromatin structure mapping |
| 04/16/2009 | WO2008021290A9 Organ-specific proteins and methods of their use |
| 04/16/2009 | WO2008021163A3 Kits and methods for determining risk for primary liver cancer |
| 04/16/2009 | WO2008002283A3 Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism |
| 04/16/2009 | WO2007075188A3 Methods for treating bacillus infection |
| 04/16/2009 | WO2007063544A3 Method and apparatus for determination of the concentration of particles in multi-component fluid systems |
| 04/16/2009 | WO2007063424A3 The modulation of immunity and ceacam1 activity |
| 04/16/2009 | WO2007036905A3 Ligand concentrating, liquid crystal biosensor system |
| 04/16/2009 | WO2007036904A3 Liquid crystal sensor system |
| 04/16/2009 | WO2007036903A3 Liquid crystal cassette |
| 04/16/2009 | WO2007035633A3 Screening assays and methods |
| 04/16/2009 | WO2007034331A3 System recommending an optimal treatment protocol |
| 04/16/2009 | WO2007032770A3 Serotonin and catecholamine segment optimization technology |
| 04/16/2009 | WO2007030451A3 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 04/16/2009 | WO2007022346A3 Cellular function underlying bone micro-structure characteristic of type 2 diabetes |
| 04/16/2009 | WO2007011569A3 Diagnostic strip coding system and related methods of use |
| 04/16/2009 | WO2007008870A3 Transgenic mice carrying hp-2 gene and uses as models for vascular diseases |
| 04/16/2009 | WO2007008583A3 Improved protein expression comparison assay results and applications |
| 04/16/2009 | WO2007008307A3 Data correction, normalization and validation for quantitative high-throughput metabolomic profiling |
| 04/16/2009 | WO2007005715A3 Staphylococcal antibodies which cross-react with fungal antigens |
| 04/16/2009 | WO2007005559A3 Tat-005 and methods of assessing and treating cancer |
| 04/16/2009 | WO2007002200A3 Mitotic index assay |
| 04/16/2009 | WO2007002087A3 Cdc6s as modifiers of the pten/akt pathway and methods of use |
| 04/16/2009 | WO2006138694A3 Rabbit monoclonal antibody against id1 protein |
| 04/16/2009 | WO2006138449A3 Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen |
| 04/16/2009 | WO2006130872A3 Peptide nucleic acid probes for analysis of microorganisms |
| 04/16/2009 | WO2006130399A3 Therapeutic combinations and methods including irm compounds |
| 04/16/2009 | WO2006128012A3 Twin arginine translocase secretory apparatus: high throughput assays and vaccine vectors related thereto |
| 04/16/2009 | WO2006127537A3 Thyroid fine needle aspiration molecular assay |
| 04/16/2009 | WO2006119291A3 Superantibody synthesis and use in detection, prevention and treatment of disease |
| 04/16/2009 | WO2006119155A3 Diagnostic serum antibody profiling |
| 04/16/2009 | WO2006116681A3 Tat-003 and methods of assessing and treating cancer |
| 04/16/2009 | WO2006113790A3 Compositions and methods for the treatment of cancer |
| 04/16/2009 | WO2006113648A3 Hn-33 compositions and methods |
| 04/16/2009 | WO2006112925A3 Cxcr3 is a gliadin receptor |
| 04/16/2009 | WO2006108183A3 Label free biosensors and cells |
| 04/16/2009 | WO2006108101A3 Devices and method for enrichment and alteration of cells and other particles |
| 04/16/2009 | WO2006105488A3 Antibodies and related molecules that bind to 161p2f10b proteins |
| 04/16/2009 | WO2006105147A3 Biological dataset profiling of cardiovascular disease and cardiovascular inflammation |
| 04/16/2009 | WO2006105142A3 Method of detecting precancerous lesions |
| 04/16/2009 | WO2006102612A3 Extracting reagent for hydrophobic analyte in whole blood |
| 04/16/2009 | WO2006102593A3 Device, system and method of detecting targets in a fluid sample |
| 04/16/2009 | WO2006102129A3 Metal mediated fluorescence superquenching assays for detection of phosphorylation and dephosphorylation of quencher-labeled substrates |
| 04/16/2009 | WO2006099620A3 Rage/diaphanous interaction and related compositions and methods |
| 04/16/2009 | WO2006099544A3 Apparatus and method for computer modeling type 1 diabetes |
| 04/16/2009 | WO2006098752A3 Ultrasensitive sensor and rapid detection of analytes |
| 04/16/2009 | WO2006096704A3 Isotopically-labeled proteome standards |
| 04/16/2009 | WO2006094223A3 Use of prostate specific antigen to predict drug response |
| 04/16/2009 | WO2006094068A3 Hdac inhibitors that promote brm expression and brm related diagnostics |
| 04/16/2009 | WO2006093845A3 A micro-fluidic fluid separation device and method |
| 04/16/2009 | WO2006091930A3 Methods and compounds for promoting vessel regression |
| 04/16/2009 | WO2006091918A3 Process, composition and kit for providing a stable whole blood calibrator/control |
| 04/16/2009 | WO2006091631A3 Degradation sensor for environmentally sensitive products and method of use |
| 04/16/2009 | WO2006091216A3 Target-specific compomers and methods of use |
| 04/16/2009 | WO2006086760A3 Diagnostic measurement of disease |
| 04/16/2009 | WO2006086345A3 Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| 04/16/2009 | WO2006086111A3 Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
| 04/16/2009 | WO2006080937A3 Screening assays for antimicrobial agents |
| 04/16/2009 | WO2006078813A3 Arginine analogs, and methods for their synthesis and use |
| 04/16/2009 | WO2006073465A3 Modified microsurfaces and methods of their manufacture |
| 04/16/2009 | WO2006063335A3 Automated extraction and purification of samples using optical tweezers |
| 04/16/2009 | WO2006060557A3 Protein arrays and methods and systems for producing the same |
| 04/16/2009 | WO2006057763A3 Method for predicting g-protein coupled receptor-ligand interactions |
| 04/16/2009 | WO2006055615A3 A method for single oxygen atom incorporation into digested peptides using peptidases |
| 04/16/2009 | WO2006045062A3 Pot1 alternative splicing variants |
| 04/16/2009 | WO2006044551A3 Methods to differentiate protein conformers |
| 04/16/2009 | WO2006044496A3 Identification and screening of triptolide target molecules |
| 04/16/2009 | WO2006039358A3 Method for assessment of the structure-function characteristics of structures in a human or animal body |
| 04/16/2009 | WO2006036882A3 Methods for determining and lowering caffeine concentration in fluids |
| 04/16/2009 | WO2006034328A3 Wnt proteins and detection and treatment of cancer |
| 04/16/2009 | WO2006034292A3 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 04/16/2009 | WO2006023972A3 cAMP REPORTERS |
| 04/16/2009 | WO2006014588A3 Nucleic acid end-labeling reagents |
| 04/16/2009 | WO2005118787A3 Method of screening candidate compounds for susceptibility to biliary excretion |
| 04/16/2009 | WO2005116611A3 Flow assay device comprising dry reagent cake |
| 04/16/2009 | WO2005116240A3 System for amplyfing optical detection cantilever deflection |
| 04/16/2009 | WO2005107364A3 Polynucleotide, polypeptides, and diagnostic methods |
| 04/16/2009 | WO2005094393A3 Methods and processes for attaching compounds to matrices |